CD4+ T lymphopenia (mean CD4+ counts < 384 cells/μl) was observed in 100% of the severe or critical cases of COVID-19 in weeks 1–4 (Figure 1A) compared to the lower limit of normal controls (RI2.5 = 384 cells/μl, Table S1). The gene discussed is CD4; the disease is COVID-19.